Casandra
Casandra Test Code PR34310Version 1 (DRAFT)
Performing Lab
Lab Prometheus LaboratoriesLab Test ID #3170
Anser ADA
Clinical Use
Order TestUse
Anser ADA is designed to monitor the therapeutic levels of adalimumab (ADA) and antibodies-to-adalimumab (ATA) in patients. This information guides clinicians in optimizing biologic dosage to ensure effective treatment and patient safety.
Special Instructions
Not provided.
Limitations
The Anser ADA test is classified as a laboratory-developed test, which means it is not cleared or approved by the FDA. Its use is limited to clinical contexts defined by its validation under CLIA regulations.
Test Details
Methodology
Immunoassay (HMSA)
Biomarkers
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2.0 mL
Minimum Volume
0.5 mL for Peds
Container
Serum Separator Tube or Red-Top Tube
Storage Instructions
Transport ambient or with a cold pack. Do not freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
Similar Tests
Other tests from different labs that may be relevant
Adalimumab Antibody, Serum
Mayo Clinic Lab
Adalimumab Interpretation
Mayo Clinic Lab
Adalimumab and Antibodies to Adalimumab Quantitation
ARUP Laboratories
Adalimumab and Anti-Adalimumab Antibody, DoseASSURE™ ADL
Labcorp
Adalimumab Drug Level and Anti‑drug Antibody for Rheumatic Diseases
Quest Diagnostics
Adalimumab Quantitative with Reflex to Antibody, Serum
Mayo Clinic Lab
Adalimumab Quantitative with Antibody, Serum
Mayo Clinic Lab
Adalimumab Drug Level and Anti‑drug Antibody for IBD
Quest Diagnostics
Adalimumab Quantitative, Serum
Mayo Clinic Lab
Adalimumab Level for Rheumatic Diseases
Quest Diagnostics